Yescommonly co-studied with metabolic peptides like MOTS-c or TB-500 for synergy
GLP-1 medicines commonly cause stomach-related side effects such as nausea, vomiting, diarrhoea, and constipation, especially at the start of treatment and during dose escalation
Cannot redeclare control with same name "grid_6_qv_ribbon_typography_font_size"
The mechanisms of this phenomenon remain unclear
The most commonly reported side effects are mild and transient, including flushing, tingling, or mild discomfort at the injection site
combined the catalysis of spatially restricted in situ protein biotinylation by peroxidase with RNAprotein chemical crosslinking, resulting in a method named APEX-RIP, which allows the highly specific and sensitive isolation of RNA from various subcellular compartments, such as the mitochondrial matrix, cell nucleus, cytoplasm, and endoplasmic reticulum [42]